Grand Pharmaceutical Group Ltd
F:MX6A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Grand Pharmaceutical Group Ltd
F:MX6A
|
HK |
Wall St Price Targets
MX6A Price Targets Summary
Grand Pharmaceutical Group Ltd
According to Wall Street analysts, the average 1-year price target for MX6A is 2.06 EUR with a low forecast of 2.014 EUR and a high forecast of 2.147 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MX6A's stock price target?
Price Target
2.06
EUR
According to Wall Street analysts, the average 1-year price target for MX6A is 2.06 EUR with a low forecast of 2.014 EUR and a high forecast of 2.147 EUR.
What is the Revenue forecast for Grand Pharmaceutical Group Ltd?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 3 years is 10%.
What is the Gross Profit forecast for Grand Pharmaceutical Group Ltd?
Projected CAGR
11%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 20%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Grand Pharmaceutical Group Ltd?
Projected CAGR
15%
Over the last 14 years, the compound annual growth rate for Operating Income has been 21%. The projected CAGR for the next 8 years is 15%.
What is the Pre-Tax Income forecast for Grand Pharmaceutical Group Ltd?
Projected CAGR
18%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 21%. The projected CAGR for the next 3 years is 18%.
What is the Net Income forecast for Grand Pharmaceutical Group Ltd?
Projected CAGR
18%
Over the last 14 years, the compound annual growth rate for Net Income has been 25%. The projected CAGR for the next 3 years is 18%.
